Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Graham Doyle
UBS
Graham Doyle
Wall Street Analyst
Not yet ranked — too few measurable calls.
50%
Success Rate
+10.6%
Average Return
1 of 2 calls profitable · +6.7% vs benchmark
📈 Across the calls we could measure, roughly 50% of Graham Doyle's ratings turned a profit when each position was held for 1 year — averaging +10.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

49 Buy 39 Hold 15 Sell
Graham's Stock Coverage 24 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
DE:FME
Fresenius Medical Care AG & Co. KGaA
Jun 09, 2026 SELL Buy
+27.6% avg upside
21 analysts
$37.00
9.05% Downside
·
DE:FRE
Fresenius SE & Co. KGaA
Jun 03, 2026 BUY Strong Buy
+29.4% avg upside
19 analysts
$54.00
36.43% Upside
·
GB:CTEC
ConvaTec
May 29, 2026 BUY Strong Buy
+41.3% avg upside
16 analysts
$375.00
81.13% Upside
·
CH:SOON
Sonova Holding AG
May 21, 2026 HOLD Sell
+14.3% avg upside
17 analysts
$206.00
6.67% Upside
·
CH:ALC
Alcon
May 21, 2026 BUY Buy
+33.9% avg upside
35 analysts
$86.00
62.72% Upside
·
FR:BIM
bioMerieux
May 21, 2026 BUY Buy
+53.7% avg upside
12 analysts
$138.00
99.95% Upside
·
GEHC
GE Healthcare Technologies Inc
May 21, 2026 HOLD Strong Buy
+36.0% avg upside
20 analysts
$69.00
11.93% Upside
-4.3%
OBCKF
Ottobock SE & Co. KGaA
May 21, 2026 BUY Strong Buy
4 analysts
$85.94
·
AMBFF
Ambu
May 21, 2026 BUY Hold
+12.3% avg upside
2 analysts
$14.92
51.39% Upside
·
GB:0QBO
Coloplast A/S
May 21, 2026 BUY Buy
+87.4% avg upside
16 analysts
$530.00
41.87% Upside
·
SE:EKTA.B
Elekta AB
May 21, 2026 SELL Sell
+23.4% avg upside
12 analysts
$39.00
19.70% Downside
·
DE:AFX
Carl Zeiss Meditec
May 12, 2026 HOLD Hold
+91.0% avg upside
13 analysts
$25.00
0.26% Upside
·
DE:SHL
Siemens Healthineers AG
May 07, 2026 HOLD Strong Buy
+51.7% avg upside
22 analysts
$51.00
48.90% Upside
·
NL:PHIA
Koninklijke Philips N.V.
May 06, 2026 BUY Buy
+31.4% avg upside
20 analysts
$32.50
38.34% Upside
·
CH:STMN
Straumann Holding AG
Apr 30, 2026 HOLD Buy
+19.9% avg upside
13 analysts
$71.32
31.77% Downside
·
CH:MOVE
Medacta Group SA
Apr 23, 2026 HOLD Buy
+10.2% avg upside
4 analysts
$151.00
12.79% Upside
·
WILLF
Demant
Apr 15, 2026 BUY Buy
+10.7% avg upside
19 analysts
$37.29
5.11% Upside
+25.5%
GB:SN
Smith & Nephew
Mar 17, 2026 HOLD Strong Buy
+1305.8% avg upside
15 analysts
$1300.00
15.50% Upside
·
GB:0QIU
Novo Nordisk
Jan 25, 2022 SELL Hold
+43.2% avg upside
28 analysts
·
CH:NOVN
Novartis AG
Jan 25, 2022 HOLD Buy
-9.8% avg upside
30 analysts
·
GB:AZN
AstraZeneca
May 29, 2020 BUY Strong Buy
+12.2% avg upside
26 analysts
·
GB:GSK
GlaxoSmithKline
May 28, 2020 HOLD Hold
-2.9% avg upside
25 analysts
·
DE:BAYN
Bayer
Jan 22, 2020 BUY Strong Buy
+33.6% avg upside
28 analysts
$90.00
137.79% Upside
·
CH:ROP
Roche Holding AG
Jun 20, 2019 HOLD Buy
+3.3% avg upside
23 analysts
$275.00
14.10% Downside
·
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Graham Doyle — Frequently Asked Questions
How accurate are Graham Doyle's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Graham's ratings were profitable over a one-year hold, with an average return of +10.6% per rating, or +6.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Graham ranked on 13Foresight?
Graham Doyle is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Graham cover?
Graham most recently has ratings on DE:FME, DE:FRE, GB:CTEC, CH:SOON, CH:ALC, FR:BIM, GEHC, OBCKF, AMBFF, GB:0QBO, SE:EKTA.B, DE:AFX and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.